Adaptive two-stage seamless sequential design for clinical trials
Adaptive two-stage seamless sequential design for clinical trials
We propose an adaptive sequential testing procedure for the selection and testing of multiple treatment options, such as dose/regimen, different drugs, sub-populations, endpoints, or a mixture of them in a seamlessly combined phase II/III trial. The selection is to be made at the end of phase 2 stage. Unlike in …